FDA Awards Fast Track Designation to Multiple Non-Covid-19 CandidatesAcid Disorders, Acute repetitive seizures, Coronavirus Disease (COVID-19) Pandemic, Fast Track Designation, FDA, Gene Therapy, Hypogammaglobulinemia, Imaging Agents, Infections and Myelokathexis) syndrome, Methylmalonic Acidemia (MMA), MPS Type VI, Non-Small Cell Lung Cancer (NSCLC), Phenylketonuria (PKU), Primary Mitochondrial Myopathy (PMM), Solid Tumors, WHIM (WartsWhile the world has largely been focused on the development of vaccines and therapeutics for Covid-19, the U.S. Food and Drug Administration has remained busy lining up potential approvals of medications for other diseases and illnesses. Read more November 4, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/11/FDA-Awards-Fast-Track-Designation-to-Multiple-Non-COVID-19-Candidates-BioSpace-11-4-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-11-04 18:55:482020-11-04 18:55:48FDA Awards Fast Track Designation to Multiple Non-Covid-19 Candidates